Dianne Lemmon

558 total citations
9 papers, 429 citations indexed

About

Dianne Lemmon is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Dianne Lemmon has authored 9 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Oncology. Recurrent topics in Dianne Lemmon's work include Prostate Cancer Treatment and Research (7 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Hormonal and reproductive studies (4 papers). Dianne Lemmon is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Hormonal and reproductive studies (4 papers). Dianne Lemmon collaborates with scholars based in United States. Dianne Lemmon's co-authors include Tomasz M. Beer, W. David Henner, Bruce A. Lowe, Christopher W. Ryan, Mark Garzotto, Emily M. Wersinger, Primo N. Lara, Philip C. Mack, Harry A. Drabkin and Bryan Goldman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Dianne Lemmon

9 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dianne Lemmon United States	7	308	121	92	87	86	9	429
Betsy Higgins United States	11	518 1.7×	123 1.0×	104 1.1×	117 1.3×	203 2.4×	17	742
W A Sakr United States	7	605 2.0×	144 1.2×	47 0.5×	112 1.3×	102 1.2×	10	738
Ignacio F. San Francisco Chile	16	588 1.9×	157 1.3×	114 1.2×	60 0.7×	95 1.1×	35	823
Masaki Shimbo Japan	14	484 1.6×	162 1.3×	169 1.8×	101 1.2×	113 1.3×	51	672
H. Ballentine Carter United States	9	268 0.9×	123 1.0×	133 1.4×	66 0.8×	173 2.0×	14	544
Tom Morris United Kingdom	7	311 1.0×	34 0.3×	97 1.1×	67 0.8×	38 0.4×	11	466
Pam Unger United States	11	451 1.5×	123 1.0×	22 0.2×	60 0.7×	65 0.8×	17	682
P C Walsh United States	9	485 1.6×	172 1.4×	58 0.6×	117 1.3×	104 1.2×	12	698
Giancarlo Comeri Italy	10	371 1.2×	54 0.4×	159 1.7×	65 0.7×	56 0.7×	17	502
Itsuhiro Takizawa Japan	11	214 0.7×	68 0.6×	102 1.1×	59 0.7×	38 0.4×	26	334

Countries citing papers authored by Dianne Lemmon

Since Specialization

Citations

This map shows the geographic impact of Dianne Lemmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianne Lemmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianne Lemmon more than expected).

Fields of papers citing papers by Dianne Lemmon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dianne Lemmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianne Lemmon. The network helps show where Dianne Lemmon may publish in the future.

Co-authorship network of co-authors of Dianne Lemmon

This figure shows the co-authorship network connecting the top 25 collaborators of Dianne Lemmon. A scholar is included among the top collaborators of Dianne Lemmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianne Lemmon. Dianne Lemmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Moinpour, Carol M., Katherine Hayden, Joseph M. Unger, et al.. (2007). Health-Related Quality of Life Results in Pathologic Stage C Prostate Cancer From a Southwest Oncology Group Trial Comparing Radical Prostatectomy Alone With Radical Prostatectomy Plus Radiation Therapy. Journal of Clinical Oncology. 26(1). 112–120. 109 indexed citations

Ryan, Christopher W., Bryan Goldman, Primo N. Lara, et al.. (2007). Sorafenib With Interferon Alfa-2b As First-Line Treatment of Advanced Renal Carcinoma: A Phase II Study of the Southwest Oncology Group. Journal of Clinical Oncology. 25(22). 3296–3301. 117 indexed citations

Garzotto, Mark, et al.. (2005). Prostate-specific antigen decline after gonadotropin-releasing hormone antagonist withdrawal in androgen-independent prostate cancer. Urology. 65(4). 799–799. 3 indexed citations

Garzotto, Mark, Thomas G. DeLoughery, Christopher W. Ryan, et al.. (2005). Phase II study of transdermal estradiol in androgen‐independent prostate carcinoma. Cancer. 103(4). 717–723. 31 indexed citations

Purnell, Jonathan Q., Dianne Lemmon, Emily M. Wersinger, et al.. (2005). Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer. Journal of Lipid Research. 47(2). 349–355. 21 indexed citations

Hayden, Katherine, Carol M. Moinpour, James R. Faulkner, et al.. (2005). Short- and long-term genitourinary symptom status and global quality of life (QOL) from a Southwest Oncology Group (SWOG) Trial. Journal of Clinical Oncology. 23(16_suppl). 4556–4556. 1 indexed citations

Beer, Tomasz M., et al.. (2004). Targeting FSH in androgen-independent prostate cancer: abarelix for prostate cancer progressing after orchiectomy. Urology. 63(2). 342–347. 31 indexed citations

Beer, Tomasz M., Dianne Lemmon, Bruce A. Lowe, & W. David Henner. (2003). High‐dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma. Cancer. 97(5). 1217–1224. 91 indexed citations

Beer, Tomasz M., et al.. (2003). Phase II Study of Abarelix Depot for Androgen Independent Prostate Cancer Progression During Gonadotropin-Releasing Hormone Agonist Therapy. The Journal of Urology. 169(5). 1738–1741. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact